The US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic ...

The increasing incidence of respiratory conditions like asthma, COPD, and bronchitis mainly drives the growth of the inhalable drugs market. Additionally, the rising prevalence of diabetes and ...

"Cilta-cel is the first CAR T-cell therapy to demonstrate an overall survival benefit in multiple myeloma," María-Victoria ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...

AbbVie (ABBV) has lowered its 2024 earnings forecast by $0.04 per share due to the impact of certain expenses it expects to ...

Pythons to highly venomous king browns, the course offered in the Northern Territory at TAFE seeks to prepare students for every kind of slithery encounter. A letter seen by the ABC shows the ...